当前位置：
X-MOL 学术
›
Signal Transduct. Target Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
High-throughput screening and evaluation of repurposed drugs targeting the SARS-CoV-2 main protease.
Signal Transduction and Targeted Therapy ( IF 40.8 ) Pub Date : 2021-09-29 , DOI: 10.1038/s41392-021-00763-5 Yan Li 1 , Jinyong Zhang 2 , Zilei Duan 3, 4 , Ning Wang 1 , Xiangcheng Sun 1 , Yanjing Zhang 5 , Li Fu 5 , Kaiyun Liu 1 , Yongjun Yang 6 , Shulei Pan 1 , Yun Shi 1 , Hao Zeng 2 , Gang Guo 1 , Ren Lai 3, 4 , Quanming Zou 2
中文翻译：
针对 SARS-CoV-2 主要蛋白酶的再利用药物的高通量筛选和评估。
更新日期：2021-09-29
Signal Transduction and Targeted Therapy ( IF 40.8 ) Pub Date : 2021-09-29 , DOI: 10.1038/s41392-021-00763-5 Yan Li 1 , Jinyong Zhang 2 , Zilei Duan 3, 4 , Ning Wang 1 , Xiangcheng Sun 1 , Yanjing Zhang 5 , Li Fu 5 , Kaiyun Liu 1 , Yongjun Yang 6 , Shulei Pan 1 , Yun Shi 1 , Hao Zeng 2 , Gang Guo 1 , Ren Lai 3, 4 , Quanming Zou 2
Affiliation
中文翻译：
针对 SARS-CoV-2 主要蛋白酶的再利用药物的高通量筛选和评估。
京公网安备 11010802027423号